NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc., (OTCBB: GTHP) (OTCQB: GTHP), today announced that it has received a total of $2.9 million to date resulting from the exercises of new warrants issued in the Company’s recent warrant exchange offer completed on July 5, 2012. In connection with the exercises of these warrants, the Company issued 7,042,682 shares of its common stock.
